AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Spiropirf Tablet

Prescription Icon
Prescription Required

Marketer

Koye Pharmaceuticals Pvt ltd

Salt Composition

Pirfenidone (200mg)

Overview Spiropirf Tablet

Idiopathic pulmonary fibrosis is treated with the prescription medication Spiropirf Tablet. This medication lessens lung scarring and inflammation, improving breathing capacity. For optimal results, take Spiropirf Tablet with food at the same time each day. Dosage and frequency depend on individual needs and are determined by your physician to manage your symptoms effectively. Continue taking this medication as directed by your doctor. Common side effects include sleep disturbances, headaches, vertigo, indigestion, nausea, loose stools, and sun sensitivity. To mitigate dizziness, refrain from driving or activities requiring intense concentration. Weight loss and other adverse reactions are possible; regular weight monitoring or consultation with your doctor is advised. Your physician may order liver function tests during treatment. Before starting Spiropirf Tablet, disclose any pre-existing liver or kidney conditions, and provide a complete list of all other medications you are currently using, as interactions can affect efficacy. Due to increased sun sensitivity, protective clothing and sunscreen are recommended during sun exposure. Notify your doctor if you are pregnant or nursing.

Primary Ingredients of Spiropirf Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Spiropirf Tablet

Managing idiopathic pulmonary fibrosis

Major Benefits of Spiropirf Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Spiropirf Tablet should be administered with a meal.

Common Side effects of Spiropirf Tablet:

  • Insomnia (difficulty in sleeping)
  • Headache
  • Dizziness
  • Tiredness
  • Sinus inflammation
  • Loss of appetite
  • Upper respiratory tract infection
  • Weight loss
  • Nausea
  • Indigestion
  • Diarrhea
  • Photosensitivity

How to use Spiropirf Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Spiropirf Tablet with a meal.

How Spiropirf Tablet works:

Niventin tablets offer antifibrotic action. They inhibit a specific endogenous compound responsible for fibrosis development, thereby lessening pulmonary scarring and inflammation, and improving respiratory function.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Spiropirf Tablet may pose unknown risks. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Spiropirf Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Spiropirf Tablet use while breastfeeding is absent. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Spiropirf Tablets may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Exercise caution when administering Spiropirf tablets to individuals with impaired renal function; dosage modifications may be necessary. Physician consultation is advised. Spiropirf tablets are contraindicated for patients experiencing severe kidney disease or undergoing dialysis.

LiverLiverCAUTION

Patients with liver impairment should use Spiropirf Tablet cautiously, potentially requiring dosage modification. Consult a physician before use. Spiropirf Tablet is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Spiropirf Tablet :

NA

Facts to Know About Spiropirf Tablet

LabelValue
Chemical Classification Pyridone derivative
Developing Habits No.
Treatment Category Breathing
Actions Pulmonary fibrosis of unknown cause

FAQs on Spiropirf Tablet

Before and during Spiropirf Tablet treatment, your doctor will monitor your liver function (monthly for the first six months, then every three months) and lung function periodically to assess treatment response.
Protecting your irreplaceable lung function is crucial to managing this disease. Therefore, your doctor's prescription of Spiropirf Tablets should be followed diligently to help maintain your current lung capacity.
Spiropirf Tablet may cause common side effects like sun sensitivity, nausea, fatigue, diarrhea, indigestion, appetite loss, and headache. Other possible side effects include upper respiratory and bladder infections, weight loss, sleep disturbances, dizziness, taste changes, hot flashes, shortness of breath, and cough. Gastrointestinal issues such as acid reflux, vomiting, bloating, abdominal pain, heartburn, and constipation may also occur. Skin reactions including itching, redness, dryness, and rash are possible, along with muscle pain, joint pain, weakness, chest pain, and sunburn. Elevated liver enzymes may be detected in blood tests.
Spiropirf Tablet is not a steroid; it's a pyridine-based medication. Used to treat idiopathic pulmonary fibrosis (IPF) in adults, it helps alleviate the lung scarring and swelling characteristic of IPF, thereby improving breathing.
You and your doctor should decide together if Spiropirf Tablet is appropriate for you. Your doctor will prescribe it only after evaluating your health. Continued use depends on your response and how well you tolerate the medication.
Idiopathic pulmonary fibrosis progresses unpredictably. Discontinue Spiropirf Tablet only after consulting your doctor. Continued use may help slow disease progression.
Minimize sun exposure while taking Spiropirf Tablets. Daily sunscreen use and covering exposed skin (arms, legs, and head) are recommended. Additionally, avoid smoking to maximize the tablet's effectiveness.
While the average lifespan for pulmonary fibrosis patients is two to three years, many individuals survive significantly longer. Reduced survival is associated with older age, smoking, and lower BMI. Further contributing factors include advanced disease severity (radiologically and functionally) and the onset of additional lung problems.
Spiropirf Tablet
183
MRP 223
17% off